Citations 181

189 Epidemiology of antiphospholipid syndrome: a population-based study

Abstracts | April 12, 2019 | Volume: No volume available | Issue: No issue available | Pages: A143.1-A143

10.1136/lupus-2019-lsm.189

The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study

Arthritis & Rheumatology | April 8, 2019 | Volume: 71 | Issue: 9 | Pages: 1545-1552

10.1002/art.40901 | PMID 30957430

Objective To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome ( APS ). Methods An inception cohort of patients with incident APS in 2000–2015 from a geographically well‐defined population was identified based on comprehensive individual medical records review. All cases met the 2006 Sydney criteria for APS (primary definition) or had a diagnosis of APS confirmed by physician consensus (secondary definition). Levels of lupus anticoagulant, IgM and IgG anticardiolipin antibodies, and anti–β2‐glycoprotein I antibodies were tested in a centralized laboratory. Incidence rates were age‐ and sex‐adjusted to the 2010 US white population. Prevalence estimates were obtained from the incidence rates, assuming that there was no increased mortality associated with APS and that migration in or out of the area was independent of disease status. Results Among this cohort in 2000–2015, 33 cases of incident APS , as defined by the Sydney criteria, were identified (mean age of patients 54.2 years; 55% female, 97% white). The annual incidence of APS in adults ages ≥18 years was 2.1 (95% confidence interval [95% CI ] 1.4–2.8) per 100,000 population. Incidence rates were similar in both sexes. The estimated prevalence of APS was 50 (95% CI 42–58) per 100,000 population, and was similar in both sexes. Six patients (18%) had a concurrent diagnosis of systemic lupus erythematosus. The most frequent clinical manifestation was deep vein thrombosis. The overall frequency of mortality among patients with APS was not significantly different from that in the general population (standardized mortality ratio 1.61, 95% CI 0.74–3.05). Conclusion APS occurred in ~2 persons per 100,000 population per year. The estimated prevalence was 50 per 100,000 population. Overall mortality was not notably different from that observed in the general population.
“Real-world” recurrence rate of cancer-associated-VTE treated with Low Molecular Weight Heparin Therapy: The Mayo Clinic Experience.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e17687-e17687

10.1200/jco.2015.33.15_suppl.e17687

Heat inactivation of extended half‐life factor VIII concentrates

Haemophilia | February 12, 2019 | Volume: 25 | Issue: 2 | Pages: No page available

10.1111/hae.13700 | PMID 30748064

Factor V Deficiency with a Thrombotic Clinical Phenotype

Seminars in Thrombosis and Hemostasis | January 18, 2019 | Volume: 45 | Issue: 01 | Pages: 108-112

10.1055/s-0038-1677041 | PMID 30630204

Self-reported reproductive health experiences in women with von Willebrand disease: a qualitative interview-based study

Journal of Obstetrics and Gynaecology | September 12, 2018 | Volume: 39 | Issue: 2 | Pages: 288-290

10.1080/01443615.2018.1472223 | PMID 30207499

Severe postoperative hemorrhage in a patient on dietary and herbal supplements

Journal of Perioperative Practice | June 11, 2018 | Volume: 28 | Issue: 10 | Pages: 263-266

10.1177/1750458918780112 | PMID 29888990

We report a case of a patient with severe postoperative bleeding complication, secondary to dietary and herbal supplements induced platelet dysfunction. This case demonstrates the importance of preoperative assessment which includes questioning the patient with regards to their dietary and herbal supplements and of stressing the importance of discontinuing them prior to surgery.
Diagnostic laboratory standardization and validation of platelet transmission electron microscopy

Platelets | June 4, 2018 | Volume: 29 | Issue: 6 | Pages: 574-582

10.1080/09537104.2018.1476682 | PMID 29863946

The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making

Journal of Women's Health | December 14, 2017 | Volume: 26 | Issue: 12 | Pages: 1350-1355

10.1089/jwh.2017.6333 | PMID 28933640

Hermansky-Pudlak syndrome subtype 5 (HPS-5) novel mutation in a 65 year-old with oculocutaneous hypopigmentation and mild bleeding diathesis: The importance of recognizing a subtle phenotype

Platelets | November 1, 2017 | Volume: 29 | Issue: 1 | Pages: 91-94

10.1080/09537104.2017.1361019 | PMID 29090612